Skin care product for nursing corticosteroid-dependent dermatitis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for dependent dermatitis and skin care products, applied in the field of beauty, can solve the problems of skin barrier structure damage, aggravation of hormone-dependent dermatitis, allergies, irritation, etc., and achieve the effect of getting rid of continued dependence, good antipruritic treatment, and alleviating discomfort
Inactive Publication Date: 2019-05-14
西安博鸿生物技术有限公司
View PDF2 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Some patients who use glucocorticoids to treat skin diseases repeatedly use them on their own, and over time they will become dependent on hormones; even a few people use glucocorticoids instead of skin care products, and use them on the normal face for a long time, causing hormone dependence dermatitis
[0004] Second, due to the irregularities in the beauty industry, in order to pursue quick effects and meet customers' psychological expectations, some professional theaters have illegally added glucocorticoids to their products. , anti-acne, anti-wrinkle" cosmetics have produced hormone dependence, unable to switch to other brands of skin care products and can only continue to use products containing hormones, many of which have evolved into hormone-dependent dermatitis
[0005] Patients with hormone-dependent dermatitis can hardly use ordinary skin care products. The main reason is that the safety verification of the first common commercially available products is generally carried out on normal skin, while the skin barrier structure of patients with hormone-dependent dermatitis is severely damaged, which is not safe for normal skin. Products with sexual problems are likely to cause skin adverse reactions in patients with hormone-dependent dermatitis, including allergies and irritations, which may cause cosmetic contact dermatitis and aggravate the risk of hormone-dependent dermatitis symptoms; the second is that patients with hormone-dependent dermatitis After discontinuing hormone products, there will be an acute rebound period of about 15 days, and the skin may have explosive inflammatory symptoms. Currently, commercially available skin care products cannot control the inflammatory symptoms of the rebound period. Patients will experience redness, swelling, Intense discomfort such as heat, pain, itching, etc., while the face loses its normal appearance
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0054] A kind of skin care product for hormone-dependent dermatitis skin care of the present embodiment comprises the following ingredients in parts by weight:
[0055] Anti-inflammatory agent 0.05-5.0%
[0056] Esters 1.0-10.0%
[0057] Grease 2.0-10.0%
[0058] Higher fatty alcohols 1.0-5.0%
[0059] Wax 1.0-3.0%
[0060] Emulsifier 2.0-4.0%
[0061] Polyol 2.0-8.0%
[0062] Thickener 0.1-0.5%
[0063] Preservatives 0.1-1.0%
[0064] The remainder is water;
[0065] The anti-inflammatory agents include glycyrrhetinic acid, Polygonum extract and / or allantoin.
Embodiment 2
[0067]In this example, on the basis of Example 1, as a preferred embodiment, the anti-inflammatory agent includes 0.05-0.5% glycyrrhetinic acid, 0.01-0.1% Polygonum extract and / or urine Bursin 0.1-1.0%.
[0068] As a preferred embodiment, it includes glycyrrhetinic acid 0.1%, or 0.15%, or 0.2%, or 0.25%, or 0.3%, or 0.35%, or 0.4%, or 0.45%, or 0.5%.
[0069] As a preferred embodiment, including 0.01%, or 0.05%, or 0.1% and / or allantoin 0.1%, or 0.2%, or 0.3%, or 0.4%, or 0.5%, or 1 %.
Embodiment 3
[0071] In this example, on the basis of Examples 1-2, as a preferred embodiment, the esters include one or more of the following substances: caprylic / capric triglyceride, tocopheryl acetate, carbonic acid Diethylhexyl, Isopropyl Isostearate, Neopentyl Glycol Dicaprylate / Caprate.
[0072] As a preferred embodiment, the grease includes one or more of the following substances: simethicone, cyclopentasiloxane, hydrogenated polyisobutylene, and shea butter.
[0073] As a preferred embodiment, the higher fatty alcohols include one or more of the following substances: cetearyl alcohol, cetyl alcohol, stearyl alcohol.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention belongs to the technical field of beautifying, and relates to a skin care product for nursing corticosteroid-dependent dermatitis. The skin care product comprises an anti-inflammatory agent, esters, oil or fat, higher aliphatic alcohols, waxes, an emulgator, polyhydric alcohols, a thickening agent, a preservative and the balance water, wherein the anti-inflammatory agent comprises glycyrrhetinic acid, a ciderage extract and / or allantoin. According to the skin care product for nursing corticosteroid-dependent dermatitis, the skin care product composition which is high in safety and good in efficacy is provided, and explosive inflammatory symptoms of patients with corticosteroid-dependent dermatitis in the acute bouncing period are effectively relieved, controlled and treated;meanwhile, the skin care product achieves good itching-relieving therapy, the discomfort of the patients is alleviated, the patients are helped to get rid of continuous dependency, so that skin of thepatients gradually restores health, and the skin care product can also be used for treating dermatitis symptoms caused by other reasons.
Description
technical field [0001] The invention belongs to the technical field of cosmetics, and relates to a skin care product, in particular to a skin care product for hormone-dependent dermatitis skin care. Background technique [0002] Hormone-dependent dermatitis is hormone dependence caused by high-frequency use of medium and strong glucocorticoid preparations to treat facial skin diseases, or abuse of glucocorticoid preparations for facial skin beauty. It is manifested as a kind of dermatitis in which the primary skin lesions disappear after topical glucocorticoids are used, but inflammatory lesions reappear after discontinuation. Repeated use of glucocorticoids is required to control symptoms and gradually aggravate. The main inflammatory symptoms are skin atrophy and thinning, hypopigmentation or pigmentation spots, telangiectasia, increased vellus hair, acne-like dermatitis, etc. The specific symptoms include erythema, papules, dry desquamation, atrophy, atrophic stria Secon...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more